Phreesia, Inc. (NYSE:PHR – Get Free Report) has been assigned a consensus rating of “Hold” from the nineteen brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, ten have given a hold recommendation and eight have given a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $14.00.
A number of research analysts recently weighed in on the stock. Wall Street Zen lowered shares of Phreesia from a “buy” rating to a “hold” rating in a research note on Saturday, September 5th. Barclays reiterated an “equal weight” rating and set a $10.00 price objective (down from $24.00) on shares of Phreesia in a research note on Thursday, May 14th. Weiss Ratings cut Phreesia from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, September 4th. Piper Sandler downgraded Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 target price on the stock. in a research report on Thursday, May 28th. Finally, Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a research note on Friday, September 4th.
View Our Latest Report on Phreesia
Phreesia Stock Performance
Phreesia (NYSE:PHR – Get Free Report) last announced its earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.06). The company had revenue of $129.46 million during the quarter, compared to analyst estimates of $129.06 million. Phreesia had a net margin of 2.06% and a return on equity of 5.22%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.01 EPS. As a group, research analysts forecast that Phreesia will post 0.33 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Phreesia
Several hedge funds and other institutional investors have recently modified their holdings of the business. Royal Bank of Canada grew its stake in Phreesia by 208.8% during the 1st quarter. Royal Bank of Canada now owns 24,119 shares of the company’s stock valued at $617,000 after acquiring an additional 16,309 shares in the last quarter. AQR Capital Management LLC lifted its stake in Phreesia by 471.2% in the 1st quarter. AQR Capital Management LLC now owns 160,032 shares of the company’s stock worth $4,090,000 after purchasing an additional 132,015 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Phreesia by 3.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company’s stock worth $1,599,000 after purchasing an additional 2,158 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in shares of Phreesia by 262.7% during the 1st quarter. NewEdge Advisors LLC now owns 15,437 shares of the company’s stock worth $395,000 after purchasing an additional 11,181 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its position in shares of Phreesia by 0.4% in the first quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company’s stock valued at $15,336,000 after purchasing an additional 2,402 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.
Phreesia Company Profile
Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.
Further Reading
- Five stocks we like better than Phreesia
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
